Treg cells directly or indirectly inhibit immune response and antibody production by expressing cellular receptors such as CTLA-4 or secreting cytokines such as TGF-β, IL-10, and IL-35, and are the therapeutic target of autoimmune diseases (14). This evidence concerns the gene TGFB1 and autoimmune disease.